Showing results (101-110 of 396) with videos related to

Sort By:
Pageof 40
Journal of the American Academy of Dermatology|July 21, 2015
Melanocytic nevi excised during B-Raf proto-oncogene (BRAF) inhibitor therapy: A study of 19 lesions from 10 patientsMark C Mochel, Marc R Hammond, Dennie T Frederick, et al.
Cancer Causes & Control : CCC|September 27, 2005
A prospective study of body mass index, hypertension, and smoking and the risk of renal cell carcinoma (United States)Keith T Flaherty, Charles S Fuchs, Graham A Colditz, et al.
The Oncologist|April 16, 2021
Efficacy and Safety of Trametinib in Non-V600 BRAF Mutant Melanoma: A Phase II StudyCaroline A Nebhan, Douglas B Johnson, Ryan J Sullivan, et al.
Cancer|April 4, 2003
Dose escalation study of tezacitabine in combination with cisplatin in patients with advanced cancerKeith T Flaherty, James P Stevenson, Maryann Gallagher, et al.
European Journal of Cancer (Oxford, England : 1990)|July 27, 2011
Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohortLu Si, Yan Kong, Xiaowei Xu, et al.
The Journal of Craniofacial Surgery|September 7, 2010
Sinus pericranii--"Don't judge a lump by its surface"Amit K Shah, Andrew C Camilleri, Peter Kirkpatrick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 4, 2009
Expression of sorafenib targets in melanoma patients treated with carboplatin, paclitaxel and sorafenibLucia Jilaveanu, Christopher Zito, Sandra J Lee, et al.
Archives of Dermatology|March 21, 2012
Photodynamic therapy for multiple eruptive keratoacanthomas associated with vemurafenib treatment for metastatic melanomaAllireza Alloo, Lilit Garibyan, Nicole LeBoeuf, et al.
Pageof 40